- Home
- NCV vs OLMA Comparison
NCV vs OLMA Comparison
Compare NCV & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCV
- OLMA
- Stock Information
- Founded
- NCV 2003
- OLMA 2006
- Country
- NCV United States
- OLMA United States
- Employees
- NCV N/A
- OLMA N/A
- Industry
- NCV Finance Companies
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NCV Finance
- OLMA Health Care
- Exchange
- NCV Nasdaq
- OLMA Nasdaq
- Market Cap
- NCV 326.0M
- OLMA 378.9M
- IPO Year
- NCV N/A
- OLMA 2020
- Fundamental
- Price
- NCV $14.75
- OLMA $5.46
- Analyst Decision
- NCV
- OLMA Strong Buy
- Analyst Count
- NCV 0
- OLMA 5
- Target Price
- NCV N/A
- OLMA $24.00
- AVG Volume (30 Days)
- NCV 405.1K
- OLMA 450.7K
- Earning Date
- NCV 01-01-0001
- OLMA 08-11-2025
- Dividend Yield
- NCV 12.48%
- OLMA N/A
- EPS Growth
- NCV N/A
- OLMA N/A
- EPS
- NCV N/A
- OLMA N/A
- Revenue
- NCV N/A
- OLMA N/A
- Revenue This Year
- NCV N/A
- OLMA N/A
- Revenue Next Year
- NCV N/A
- OLMA N/A
- P/E Ratio
- NCV N/A
- OLMA N/A
- Revenue Growth
- NCV N/A
- OLMA N/A
- 52 Week Low
- NCV $2.84
- OLMA $2.86
- 52 Week High
- NCV $3.59
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- NCV 66.05
- OLMA 54.42
- Support Level
- NCV $14.27
- OLMA $5.54
- Resistance Level
- NCV $14.78
- OLMA $5.85
- Average True Range (ATR)
- NCV 0.14
- OLMA 0.30
- MACD
- NCV 0.01
- OLMA -0.01
- Stochastic Oscillator
- NCV 90.57
- OLMA 51.79
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.